Close Menu

NEW YORK – XPrize and nonprofit OpenCovidScreen announced this week that they’re holding a competition to accelerate the development of low-cost, high-quality COVID-19 testing solutions to ultimately scale testing capabilities by 100 times the current capacity. The XPrize Rapid COVID Testing Competition is asking for tests and devices with fast turnaround times that are easy to use in one of four categories: At-Home, Point-of-Care, Distributed Lab, or High-Throughput Lab.  

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.